Thor Alvegård

affiliated with the university
More filtering options
  1. 2017
  2. The Scandinavian Sarcoma Group Central Register: 6,000 patients after 25 years of monitoring of referral and treatment of extremity and trunk wall soft-tissue sarcoma

    Clement Trovik, Henrik C F Bauer, Emelie Styring, Kirsten Sundby Hall, Fredrik Vult Von Steyern, Sigvard Eriksson, Ingela Johansson, Mika Sampo, Minna Laitinen, Anders Kalén, Halldór Jónsson, Nina L Jebsen, Mikael Eriksson, Erkki Tukiainen, Najme Wall, Olga Zaikova, Helgi Sigurðsson, Tuula Lehtinen, Bodil Bjerkehagen, Mikael Skorpil & 3 others, Geir Egil Eide, Elisabeth Johansson & Thor A. Alvegard, 2017 Mar 7, In : Acta Orthopaedica. 88, 3, p. 341-347

    Research output: Contribution to journalArticle

  3. 2016
  4. Adjuvant Imatinib for High-Risk GI Stromal Tumor: Analysis of a Randomized Trial.

    Heikki Joensuu, Mikael Eriksson, Kirsten Sundby Hall, Annette Reichardt, Jörg T Hartmann, Daniel Pink, Giuliano Ramadori, Peter Hohenberger, Salah-Eddin Al-Batran, Marcus Schlemmer, Sebastian Bauer, Eva Wardelmann, Bengt Nilsson, Harri Sihto, Petri Bono, Raija Kallio, Jouni Junnila, Thor Alvegård & Peter Reichardt, 2016, In : Journal of Clinical Oncology. 34, 3, p. 244-250

    Research output: Contribution to journalArticle

  5. Needle biopsy through the abdominal wall for the diagnosis of gastrointestinal stromal tumour - Does it increase the risk for tumour cell seeding and recurrence?

    Mikael Eriksson, Peter Reichardt, Kirsten Sundby Hall, Jochen Schütte, Silke Cameron, Peter Hohenberger, Sebastian Bauer, Mika Leinonen, Annette Reichardt, Maria Rejmyr Davis, Thor Alvegård & Heikki Joensuu, 2016, In : European Journal of Cancer. 59, p. 128-133 6 p.

    Research output: Contribution to journalArticle

  6. 2014
  7. 2012
  8. One vs Three Years of Adjuvant Imatinib for Operable Gastrointestinal Stromal Tumor: A Randomized Trial

    Heikki Joensuu, Mikael Eriksson, Kirsten Sundby Hall, Joerg T. Hartmann, Daniel Pink, Jochen Schuette, Giuliano Ramadori, Peter Hohenberger, Justus Duyster, Salah-Eddin Al-Batran, Marcus Schlemmer, Sebastian Bauer, Eva Wardelmann, Maarit Sarlomo-Rikala, Bengt Nilsson, Harri Sihto, Odd R. Monge, Petri Bono, Raija Kallio, Aki Vehtari & 3 others, Mika Leinonen, Thor Alvegård & Peter Reichardt, 2012, In : JAMA: The Journal of the American Medical Association. 307, 12, p. 1265-1272

    Research output: Contribution to journalArticle

  9. 2011
  10. Nonmetastatic Ewing family tumors: high-dose chemotherapy with stem cell rescue in poor responder patients. Results of the Italian Sarcoma Group/Scandinavian Sarcoma Group III protocol

    S. Ferrari, K. Sundby Hall, R. Luksch, A. Tienghi, Thomas Wiebe, F. Fagioli, Thor Alvegård, A. Brach del Prever, A. Tamburini, M. Alberghini, L. Gandola, M. Mercuri, R. Capanna, S. Mapelli, A. Prete, M. Carli, P. Picci, E. Barbieri, G. Bacci & S. Smeland, 2011, In : Annals of Oncology. 22, 5, p. 1221-1227

    Research output: Contribution to journalArticle

  11. Results of the Scandinavian Sarcoma Group XIV protocol for classical osteosarcoma 63 patients with a minimum follow-up of 4 years

    Sigbjorn Smeland, Oyvind S. Bruland, Lars Hjorth, Otte Brosjo, Bodil Bjerkehagen, Gustaf Osterlundh, Ake Jakobson, Kirsten Sundby Hall, Odd R. Monge, Olle Bjork & Thor Alvegård, 2011, In : Acta Orthopaedica. 82, 2, p. 211-216

    Research output: Contribution to journalArticle

  12. 2009
  13. Scandinavian experience in classical osteosarcoma Results of the SSG XIV protocol

    Sigbjorn Smeland, Oyvind S. Bruland, Lars Hjorth, Otte Brosjo, Bodil Bjerkehagen, Gustaf Osterlundh, Ake Jakobson, Kirsten Sundby Hall, Odd R. Monge, Olle Bjork & Thor Alvegård, 2009, In : Acta Orthopaedica. 80, p. 60-66

    Research output: Contribution to journalArticle

  14. The European postmarketing adult Osteosarcoma Surveillance Study: characteristics of patients A preliminary report

    Birgitta von Scheele, Rebecca D. Martin, Alicia W. Gilsenan, Jeanette Ceberg, Elizabeth B. Andrews, Daniel Masica & Thor Alvegård, 2009, In : Acta Orthopaedica. 80, p. 67-74

    Research output: Contribution to journalArticle

  15. The Scandinavian Sarcoma Group Register 1986-2008

    Henrik C. F. Bauer, Jan Ahlen, Thor Alvegård, Orjan Berlin, Gunnar Folleras, Anders Rydholm, Kirsten Sundby Hall, Clement S. Trovik & Fredrik Vult von Steyern, 2009, In : Acta Orthopaedica. 80, Suppl. 334, p. 13-14

    Research output: Contribution to journalArticle

  16. The Scandinavian Sarcoma Group Summary of the first 30 years

    Thor Alvegård, Henrik C. F. Bauer, Paula Lindholm, Anders Rydholm, Svante Sigurdsson & Kirsten Sundby Hall, 2009, In : Acta Orthopaedica. 80, Suppl. 334, p. 3-12

    Research output: Contribution to journalArticle

  17. Translocation-related sarcomas.

    Fredrik Mertens, Cristina R Antonescu, Peter Hohenberger, Marc Ladanyi, Piergiorgio Modena, Maurizio D'Incalci, Paolo G Casali, Massimo Aglietta & Thor Alvegård, 2009, In : Seminars in Oncology. 36, 4, p. 312-323

    Research output: Contribution to journalArticle

  18. Treatment of localized Ewing sarcoma family of tumors The Scandinavian Sarcoma Group experience

    Sigbjorn Smeland, Thomas Wiebe, Odd R. Monge, Otte Brosjo, Tom Bohling, Lars Hjorth, Kirsten Sundby Hall, Ake Jakobson & Thor Alvegård, 2009, In : Acta Orthopaedica. 80, p. 75-78

    Research output: Contribution to journalArticle

  19. 2008
  20. Direct hospital resource utilization and costs of treating patients with multiple myeloma in Southwest Sweden: a 5-year retrospective analysis.

    Ola Ghatnekar, Thor Alvegård, Nils Conradi, Stig Lenhoff, Ulf-Henrik Mellqvist, Ulf Persson & Mickael Löthgren, 2008, In : Clinical Therapeutics. 30, 9, p. 1704-1713

    Research output: Contribution to journalArticle

  21. 2006
  22. May P-glycoprotein status be used to stratify high-grade osteosarcoma patients? Results from the Italian/Scandinavian Sarcoma Group 1 treatment protocol

    Massimo Serra, Michela Pasello, Maria Cristina Manara, Katia Scotlandi, Stefano Ferrari, Franco Bertoni, Mario Mercuri, Thor Alvegård, Piero Picci, Gaetano Bacc & Sigbjorn Smeland, 2006, In : International Journal of Oncology. 29, 6, p. 1459-1468

    Research output: Contribution to journalArticle

  23. 2005
  24. Neoadjuvant chemotherapy with high-dose ifosfamide, high-dose methotrexate, cisplatin, and doxorubicin for patients with localized osteosarcoma of the extremity: A joint study by the Italian and Scandinavian Sarcoma Groups

    S Ferrari, S Smeland, M Mercuri, F Bertoni, A Longhi, P Ruggieri, Thor Alvegård, P Picci, R Capanna, G Bernini, C Muller, A Tienghi, Thomas Wiebe, A Comandone, T Bohling, AB Del Prever, O Brosjo, G Bacci & G Saeter, 2005, In : Journal of Clinical Oncology. 23, 34, p. 8845-8852

    Research output: Contribution to journalArticle

  25. The influence of surgical volume on hospital mortality and 5-year survival for carcinoma of the oesophagus and gastric cardia.

    Jörgen Wenner, Thomas Zilling, Anna Bladström & Thor Alvegård, 2005, In : Anticancer research. 25, 1B, p. 419-424

    Research output: Contribution to journalArticle

  26. 2004
  27. Chemotherapy in Ewing's sarcoma: The Scandinavian Sarcoma Group experience

    S. Smeland, Thomas Wiebe, O. Brosjö, T. Böhling & Thor Alvegård, 2004, In : Acta Orthopaedica Scandinavica. 75, Supplement 311, p. 87-91

    Research output: Contribution to journalArticle

  28. Chemotherapy in osteosarcoma: The Scandinavian Sarcoma Group experience

    S. Smeland, Thomas Wiebe, T. Böhling, O. Brosjö, Kjell Jonsson & Thor Alvegård, 2004, In : Acta Orthopaedica Scandinavica. 75, Supplement 311, p. 92-98

    Research output: Contribution to journalArticle

  29. Expression profiling using tissue microarray in 211 malignant fibrous histiocytomas confirms the prognostic value of Ki-67.

    Jacob Engellau, Annette Persson, Pär-Ola Bendahl, Måns Åkerman, Henryk Domanski, Bodil Bjerkehagen, Peer Lilleng, Johan Weide, Anders Rydholm, Thor Alvegård & Mef Nilbert, 2004, In : Virchows Archiv: an international journal of pathology. 445, 3, p. 224-230

    Research output: Contribution to journalArticle

  30. Hospital stay related to TNM-stage and the surgical procedure in primary breast cancer

    R Lindqvist, Thor Alvegård, Per-Ebbe Jönsson & M Stenbeck, 2004, In : Acta Oncologica. 43, 6, p. 545-550

    Research output: Contribution to journalArticle

  31. The Scandinavian Sarcoma Group--background, organization and the SSG Register--the first 25 years

    Thor Alvegård, H. Bauer, C. Blomqvist, Anders Rydholm & S. Smeland, 2004, In : Acta Orthopaedica Scandinavica. Supplementum. 75, Supplement 311, p. 1-7

    Research output: Contribution to journalArticle

  32. The Scandinavian Sarcoma Group Register 1986-2001

    H. C. F Bauer, Thor Alvegård, Ö. Berlin, M. Erlanson, A. Kalén, P. Lindholm, Pelle Gustafson, S. Smeland & C.S. Trovik, 2004, In : Acta Orthopaedica Scandinavica. 75, Supplement 311, p. 8-10

    Research output: Contribution to journalArticle

  33. Time dependence of prognostic factors for patients with soft tissue sarcoma: a Scandinavian Sarcoma Group Study of 338 malignant fibrous histiocytomas

    Jacob Engellau, Harald Anderson, Anders Rydholm, Henrik C F Bauer, Kirsten Sundby Hall, Pelle Gustafson, Måns Åkerman, Jeanne Meis-Kindblom, Thor Alvegård & Mef Nilbert, 2004, In : Cancer. 100, 10, p. 2233-2239 7 p.

    Research output: Contribution to journalArticle

  34. 2003
  35. Prognostic information in soft tissue sarcoma using tumour size, vascular invasion and microscopic tumour necrosis-the SIN-system.

    Pelle Gustafson, Måns Åkerman, Thor Alvegård, J-M Coindre, C D M Fletcher, Anders Rydholm & H Willén, 2003, In : European Journal of Cancer. 39, 11, p. 1568-1576

    Research output: Contribution to journalArticle

  36. Prostate cancer - Prevalence-based healthcare costs

    A Norlund, Thor Alvegård, T Lithman, Juan Merlo & D Noreen, 2003, In : Scandinavian Journal of Urology and Nephrology. 37, 5, p. 371-375

    Research output: Contribution to journalArticle

  37. Scandinavian Sarcoma Group Osteosarcoma Study SSG VIII: prognostic factors for outcome and the role of replacement salvage chemotherapy for poor histological responders

    S Smeland, C Muller, Thor Alvegård, T Wiklund, Thomas Wiebe, O Bjork, AE Stenwig, H Willen, T Holmstrom, G Folleras, O Brosjo, A Kivioja, Kjell Jonsson, O Monge & G Saeter, 2003, In : European Journal of Cancer. 39, 4, p. 488-494

    Research output: Contribution to journalArticle

  38. The cost of treating pancreatic cancer--a cohort study based on patients' records from four hospitals in Sweden.

    Jonas Hjelmgren, Jeanette Ceberg, Ulf Persson & Thor Alvegård, 2003, In : Acta Oncologica. 42, 3, p. 218-226

    Research output: Contribution to journalArticle

  39. 2001
  40. Computed tomography of pulmonary metastases from osteosarcoma: The less poor technique. A study of 51 patients with histological correlation

    P. Picci, D. Vanel, A. Briccoli, K. Talle, U. Haakenaasen, C. Malaguti, C. Monti, C. Ferrari, G. Bacci, G. Saeter & Thor Alvegård, 2001, In : Annals of Oncology. 12, 11, p. 1601-1604

    Research output: Contribution to journalArticle

  41. Monitoring referral and treatment in soft tissue sarcoma: study based on 1,851 patients from the Scandinavian Sarcoma Group Register

    Henrik C. F Bauer, Clement S. Trovik, Thor Alvegård, Örjan Berlin, Martin Erlanson, Pelle Gustafson, Ragnhild Klepp, Torgil R Möller, Anders Rydholm, Gunnar Saeter, Ola Wahlström & Tom Wiklund, 2001, In : Acta Orthopaedica Scandinavica. 72, 2, p. 150-159

    Research output: Contribution to journalArticle

  42. Tissue microarray technique in soft tissue sarcoma: immunohistochemical Ki-67 expression in malignant fibrous histiocytoma

    Jacob Engellau, Måns Åkerman, Harald Anderson, Henryk Domanski, Eva Rambech, Thor Alvegård & Mef Nilbert, 2001, In : Applied Immunohistochemistry & Molecular Morphology. 9, 4, p. 358-363

    Research output: Contribution to journalArticle

  43. 2000
  44. Five-year results in Ewing's sarcoma. The Scandinavian Sarcoma Group experience with the SSG IX protocol

    I Elomaa, C P Blomqvist, G Saeter, M Akerman, E Stenwig, Thomas Wiebe, O Bjork & Thor Alvegård, 2000, In : European Journal of Cancer. 36, 7, p. 875-880

    Research output: Contribution to journalArticle

  45. 1999
  46. Chemotherapy in Ewing's sarcoma. The Scandinavian Sarcoma Group experience

    I Elomaa, C Blomqvist, G Saeter, Mef Nilbert, O R Monge, Thomas Wiebe & Thor Alvegård, 1999, In : Acta Orthopaedica Scandinavica. Supplementum. 70, 285, p. 69-73

    Research output: Contribution to journalArticle

  47. Chemotherapy in osteosarcoma. The Scandinavian Sarcoma Group experience

    G Saeter, Thomas Wiebe, T Wiklund, O Monge, Y Wahlqvist, K Engstrom, E Forestier, T Holmstrom, A E Stenwig, H Willen, O Brosjo, G Folleras, Thor Alvegård & H Strander, 1999, In : Acta Orthopaedica Scandinavica. Supplementum. 70, 285, p. 74-82

    Research output: Contribution to journalArticle

  48. Clinical course in synovial sarcoma: A Scandinavian sarcoma group study of 104 patients

    Björn T. Skytting, Henrik C.F. Bauer, Roland Perfekt, Riika Huuhtanen, Thor A. Alvegârd, Örjan Berlin, Pelle Gustafson, Ragnhild Klepp, Richard Löfvenberg, Gunnar Seter, Clement S. Trovik & Ola Wahlström, 1999, In : Acta Orthopaedica Scandinavica. 70, 6, p. 536-542

    Research output: Contribution to journalArticle

  49. 1997
  50. Chemotherapy for osteosarcoma and Ewing's sarcoma

    G Saeter, Thor Alvegård, I Elomaa, Thomas Wiebe, O Bjork, H Strander & O P Solheim, 1997, In : Acta Orthopaedica Scandinavica. Supplementum. 68, 273, p. 120-125

    Research output: Contribution to journalArticle

  51. Prognostic factors in bone sarcomas

    G Saeter, I Elomaa, Y Wahlqvist, Thor Alvegård, Thomas Wiebe, O Monge, E Forrestier & O P Solheim, 1997, In : Acta Orthopaedica Scandinavica. Supplementum. 68, 273, p. 156-160

    Research output: Contribution to journalArticle

  52. 1996
  53. Urokinase-plasminogen-activator levels and prognosis in 69 soft-tissue sarcomas

    Peter F.M. Choong, Mårten Fernö, Mans Åkermans, Helena Willëm, Eva Lånoström, Pelle Gustafson, Thor Alvegård & Anders Rydholm, 1996 Sep 22, In : International Journal of Cancer. 69, 4, p. 268-272 5 p.

    Research output: Contribution to journalArticle

  54. 1995
  55. Expression of proliferating cell nuclear antigen (PCNA) and Ki‐67 in soft tissue sarcoma. Is prognostic significance histotype‐specific?

    PETER F.M. CHOONG, MÅNS ÅKERMAN, HELENA WILLÉN, CHRISTINA ANDERSSON, PELLE GUSTAFSON, THOR ALVEGÅRD & ANDERS RYDHOLM, 1995 Jan 1, In : APMIS. 103, 7-8, p. 797-805 9 p.

    Research output: Contribution to journalReview article

  56. The Sarcoma Group

    Anders Rydholm & Thor Alvegård, 1995, In : Acta Orthopaedica Scandinavica. 66, sup265, p. 89-100 12 p.

    Research output: Contribution to journalArticle

  57. 1994
  58. Prognostic value of Ki-67 expression in 182 soft tissue sarcomas. Proliferation--a marker of metastasis?

    P F Choong, Måns Åkerman, H Willen, C Andersson, P Gustafson, Bo Baldetorp, Mårten Fernö, Thor Alvegård & Anders Rydholm, 1994, In : APMIS : acta pathologica, microbiologica, et immunologica Scandinavica. 102, 12, p. 915-924

    Research output: Contribution to journalArticle

  59. 1991
  60. Malignant fibrous histiocytoma of soft tissue - A population-based epidemiologic and prognostic study of 137 patients

    B. Rooser, H. Willen, P. Gustafson, T. A. Alvegard & A. Rydholm, 1991 Dec 1, p. 67. 1 p.

    Research output: Contribution to conferencePaper, not in proceeding

  61. Limb-sparing surgery without radiotherapy based on anatomic location of soft tissue sarcoma

    A. Rydholm, P. Gustafson, B. Rooser, H. Willen, M. Akerman, K. Herrlin & T. Alvegard, 1991 Jan 1, In : Journal of Clinical Oncology. 9, 10, p. 1757-1765 9 p.

    Research output: Contribution to journalArticle

  62. Malignant fibrous histiocytoma of soft tissue. A population‐based epidemiologic and prognostic study of 137 patients

    Bo Rööser, Helena Willén, Pelle Gustafson, Thor A. Alvegård & Anders Rydholm, 1991 Jan 1, In : Cancer. 67, 2, p. 499-505 7 p.

    Research output: Contribution to journalArticle

  63. 1990
  64. Calculation and measurements of absorbed dose in total body irradiation

    Gudrun Svahn-Tapper, Per Nilsson, Christel Jönsson & Thor Alvegård, 1990, In : Acta Oncologica. 29, 5, p. 627-633

    Research output: Contribution to journalArticle